Bio Path Holdings News

BPTHDelisted Stock  USD 0.19  0.01  5.00%   
Under 61% of Bio Path's investor base is looking to short. The analysis of overall sentiment of trading Bio Path Holdings otc stock suggests that many investors are alarmed at this time. Bio Path's investing sentiment shows overall attitude of investors towards Bio Path Holdings.
  
over six months ago at finance.yahoo.com         
Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. Q1 24
Yahoo News
over six months ago at globenewswire.com         
Bio-Path Holdings Presents Data from Ongoing Phase 2 Combination Study of Prexigebersen for Treatmen...
Macroaxis News: globenewswire.com
over six months ago at finance.yahoo.com         
Bio-Path Holdings Presents Data from Ongoing Phase 2 Combination Study of Prexigebersen for Treatmen...
Yahoo News
over six months ago at benzinga.com         
Whats Going On With Bio-Path Stock?
benzinga news
over six months ago at investing.com         
Bio-Path stock holds price target on positive Phase 2 data
Investing News at Macroaxis
over six months ago at benzinga.com         
Crude Oil Down Over 3 US Construction Spending Falls In May
benzinga news
over six months ago at news.google.com         
Bio-Path Holdings to Present Research at Major 2024 Events - TipRanks.com - TipRanks
Google News at Macroaxis
over six months ago at finance.yahoo.com         
Bio-Path Holdings to Present Data at 2024 European Hematology Association Congress
Yahoo News
over six months ago at finance.yahoo.com         
Bio-Path Holdings to Present Data at American Society of Clinical Oncology Annual Meeting
Yahoo News
over six months ago at benzinga.com         
Bio-Path Holdings to Present Data at American Society of Clinical Oncology Annual Meeting
benzinga news
over six months ago at news.google.com         
Bio-Path Holdings, Inc. to Post Q2 2024 Earnings of Per Share, Roth Capital Forecasts - Defense Worl...
Google News at Macroaxis
over six months ago at gurufocus.com         
Bio-Path Holdings Inc Q1 2024 Earnings Call Transcript Highlights Strategic Advances ...
Gurufocus Stories at Macroaxis
over six months ago at insidermonkey.com         
Bio-Path Holdings, Inc. Q1 2024 Earnings Call Transcript
insidermonkey News
over six months ago at finance.yahoo.com         
Bio-Path Q1 Earnings Snapshot
Yahoo News
over six months ago at investorplace.com         
BPTH Stock Earnings Bio-Path Holdings Misses EPS for Q1 2024
sbwire news
Far too much social signal, news, headlines, and media speculation about Bio Path that are available to investors today. That information is available publicly through Bio media outlets and privately through word of mouth or via Bio internal channels. However, regardless of the origin, that massive amount of Bio data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Bio Path news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Bio Path relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Bio Path's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Bio Path alpha.

Bio Path Performance against Dow Jones

 Price Growth (%)  
JavaScript chart by amCharts 3.21.15Dec2025Feb -200204060
JavaScript chart by amCharts 3.21.15Bio Path Holdings Bio Path Holdings Dividend Benchmark Dow Jones Industrial
       Timeline  
Check out Bio Path Hype Analysis, Bio Path Correlation and Bio Path Performance.
You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

Other Consideration for investing in Bio OTC Stock

If you are still planning to invest in Bio Path Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bio Path's history and understand the potential risks before investing.
Global Correlations
Find global opportunities by holding instruments from different markets
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
News Freq…Investor S…